Sickle cell trait linked with higher risk of COVID-19 death in those of African ancestry

Among patients with African ancestry, those with sickle cell trait are at a higher risk for COVID-19–related death, according to data published in JAMA Internal Medicine.
Further, investigators found sickle cell trait (SCT) correlated with preexisting kidney comorbidities, increased COVID-19 mortality and kidney morbidity
“SCT affects more than 3 million people in the U.S. and 300 million people globally, but because it is not routinely assessed, there is a paucity of data on the association between SCT and COVID-19 outcomes,” Anurag Verma, PhD, from Corporal Michael J.

Among patients with African ancestry, those with sickle cell trait are at a higher risk for COVID-19–related death, according to data published in JAMA Internal Medicine.
Further, investigators found sickle cell trait (SCT) correlated with preexisting kidney comorbidities, increased COVID-19 mortality and kidney morbidity
“SCT affects more than 3 million people in the U.S. and 300 million people globally, but because it is not routinely assessed, there is a paucity of data on the association between SCT and COVID-19 outcomes,” Anurag Verma, PhD, from Corporal Michael J.